| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |